Letter to the editor
Non-random distribution of gastric cancer susceptible loci on human chromosomes
Ghazale Mahjoub1, Mostafa Saadat1
1Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
EXCLI J 2018;17:Doc802
Dear Editor,
It has been well established that many molecular alterations are involved in the etiology of cancers. Genetic studies indicated that gastric cancer (GC) has significant heritability in human populations (Graham et al., 1994[10]; Drăghicescu et al., 1998[6]; Gao et al., 2011[7]) through different molecular and genetics features (Gigek et al., 2017[8]). In order to find the genetic elements involved, many studies investigated the association of genetic variations of a wide range of candidate genes. Meta-analyses studies have shown significant associations of many polymorphisms of candidate loci with the risk of GC at least in a specific ethnic group.
Numerous data revealed the non-randomness distribution of genes on human chromosomes (Hecht 1988[13]; Lima-de-Faria et al., 1991[22]; Mouchiroud et al., 1991[33]; Saccone et al., 1996[45]; Musio et al., 2002[34]; Rafiee et al., 2008[40]). Previously our study group has reported that polymorphic loci which were associated with the risk of breast cancer (Saify and Saadat, 2012[46]), Alzheimer's disease (Saadat, 2016[44]), schizophrenia (Saadat, 2013[42]), Parkinson's disease and multiple sclerosis (Saadat, 2014[43]) are non-randomly dispersed on human chromosomes. Based on our knowledge, there is no published data about randomness of distribution of the GC susceptible loci on human chromosomes. Therefore the present study was carried out.
A literature database (PubMed) was searched for relevant studies (the last search was updated in February 2018). The following search terms were used: Gastric cancer, meta-analysis, and genetic polymorphism. The search was limited to articles published in English. There were significant associations between genetic polymorphisms of 64 genes and the risk of GC in at least one human ethnic groups. Table 1(Tab. 1) (References in Table 1: Chang et al., 2014[1]; Chen et al., 2015[2]; Cheng et al., 2015[3]; Dai et al., 2015[4]; Deng et al., 2014[5]; Gong et al., 2016[9]; Han et al., 2012[11]; He et al., 2013[12]; Hua et al., 2014[14]; Jia et al., 2017[16]; Kuang et al., 2014[17]; Li et al., 2015[20]; Li et al., 2016[18]; Li et al., 2017[19]; Liang et al., 2018[21]; Liu et al., 2011[23]; Liu et al., 2011[24]; Liu et al., 2014[25]; Liu et al., 2014[26]; Lu et al., 2012[27]; Ma et al., 2013[29]; Ma et al., 2013[30]; Ma et al., 2017[28]; Mo et al., 2016[31]; Mocellin et al., 2015[32]; Namazi et al., 2018[35]; Pabalan et al., 2015[36]; Peng and Xu, 2015[37]; Qi et al., 2016[38]; Qin et al., 2017[39]; Ribeiro et al., 2017[41]; Shen et al., 2014[47]; Shi et al., 2014[48]; Shi et al., 2017[49]; Shi et al., 2018[50]; Tian et al., 2012[52]; Wang et al., 2013[53]; Wang et al., 2014[54]; Wang et al., 2015[56]; Wang et al., 2015[57]; Wang et al., 2016[55]; Wu et al., 2015[58]; Xie et al., 2017[59]; Xu et al., 2014[61]; Xu et al., 2014[63]; Xu et al., 2015[62]; Xu et al., 2018[60]; Yadav et al., 2018[64]; Yan et al., 2013[65]; Yang et al., 2014[66]; Yang et al., 2016[67]; Ye et al., 2017[68]; Yu et al., 2014[69]; Zhang et al., 2012[72]; Zhang et al., 2013[71]; Zhang et al., 2015[74]; Zhang et al., 2016[70]; Zhang et al., 2016[73]; Zhao et al., 2014[75]; Zhou et al., 2014[76]) summarized these studies.
To evaluate the randomness/non-randomness distribution of GC susceptible loci on chromosomes, the statistical method of Tai and his colleagues (1993[51]) was used. The relative width of human chromosomal band was determined using the diagram of the International System for Chromosome Nomenclature (ISCN, 1981[15]). P-values less than 0.05 were considered as significant differences.
Analysis revealed that the 64 susceptible loci were distributed non-randomly on chromosome segments. The 1q22 (P<0.001), 2q14.1 (P<0.001), 5q31-q33 (P<0.001), 6p12-p21 (P<0.001), 10q23 (P<0.001), 11q13-q22 (P=0.025), 12q13.13 (P<0.001), 16q22.1 (P<0.001), 17q21-q25 (P<0.001), 19p13 (P=0.025) and 19q13 (P=0.025) were bearing higher numbers of GC susceptible loci. The human chromosome segments 6p12-p21, 17q21-q25, and 11q13-q22 were bearing seven (IL-17A, IL-17F, VEGFA, CDKN1A, TNF-α, LTA, and HspA1B), five (TP53, BRCA1, NME1, ACE, TIMP-2, and BIRC5) and four (GSTP1, CCND1, MMP7, and MMP1) GC susceptible genes, respectively.
The current findings have two significant aspects:
1. Distribution of the susceptible genes is not random throughout the human chromosomes.
2. The present findings help investigators to design a mass screening test tool for finding high risk persons to GC using the genetic polymorphisms in above-mentioned segments.
Previously it has been reported that human chromosome segments 10q23.3-q24.3, 16q13-q22.1, 17q12-q23, 19q13.1-q13.4, 22q11.2-q13.2 were significantly bearing breast cancer susceptible loci (Saify and Saadat, 2012[46]). Comparing with the present findings, the segments 10q23, 16q22.1, 17q12-q23, and 19q13 revealed significant associations with both gastric and breast cancers.
Acknowledgements
The authors are indebted to Dr. Maryam Ansari-Lari for critical reading of the manuscript. This study was supported by Shiraz University, Iran.
Conflict of interest
None.
References
1.
Chang WW, Zhang L, Su H, Yao YS. An updated meta-analysis of transforming growth factor-β1 gene: three polymorph-isms with gastric cancer. Tumour Biol. 2014;35:2837-44.2.
Chen L, Lu N, Zhang BH, Weng LI, Lu J. Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls. Oncol Lett. 2015;10:1159-65.3.
Cheng S, Wang L, Wang L, Wang Z. Association of XRCC3 gene rs861539 polymorphism with gastric cancer risk: evidence from a case-control study and a meta-analysis. Int J Clin Exp Pathol. 2015;8:1911-9.4.
Dai ZJ, Shao YP, Kang HF, Tang W, Xu D, Zhao Y, et al. Relationship between apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal cancer risk: An updated meta-analysis. World J Gastroenterol. 2015;21:5081-9.5.
Deng QW, He BS, Pan YQ, Sun HL, Xu YQ, Gao TY, et al. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2014;15:3705-13.6.
Drăghicescu T, Roman IC, Păltănea L. Epidemiologic research on the genetic risk factors in gastric and colorectal cancer. Rom J Morphol Embryol. 1998;44:149-52. 7.
Gao S, Zhang X, Wang P, Dai L, Zhang J, Wang K. Genetic epidemiological analysis reveals a multi-gene additive model for gastric cancer. Fam Cancer. 2011;10:119-25. 8.
Gigek CO, Calcagno DQ, Rasmussen LT, Santos LC, Leal MF, Wisnieski F, et al. Genetic variants in gastric cancer: Risks and clinical implications. Exp Mol Pathol. 2017;103:101-11.9.
Gong AM, Li XY, Xie YQ, Jia ZD, Li YX, Zou YY, et al. Association between CD14 SNP -159 C/T and gastric cancer: an independent case-control study and an updated meta-analysis. Onco Targets Ther. 2016;9:4337-42.10.
Graham DY, Malaty HM, Go MF. Are there susceptible hosts to Helicobacter pylori infection? Scand J Gastroenterol Suppl. 1994;205:6-10.11.
Han F, Wang X, Wang X, Luo Y, Li W. Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking. Mol Biol Rep. 2012;39:8335-44.12.
He Y, Xu X, Chen H, Wang J, Xiong W, Xu Y, et al. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis. Gene. 2013;523:199-204.13.
Hecht F. Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bands. Cancer Genet Cytogenet. 1988;31:17-24. 14.
Hua RX, Li HP, Liang YB, Zhu JH, Zhang B, Ye S, et al. Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies. PLoS One. 2014;9:e87057.15.
ISCN. An international system for human cytogenetic nomenclature-high resolution banding. Cytogenet Cell Genet. 1981;31:1-23.16.
Jia Y, Xie X, Shi X, Li S. Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis. Mol Med Rep. 2017;16:1927-45.17.
Kuang D, Chen W, Song YZ, Yu YY, Zhang DY, Wu L, et al. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies. Asian Pac J Cancer Prev. 2014;15:6855-61.18.
Li H, Li W, Liu S, Zong S, Wang W, Ren J, et al. DNMT1, DNMT3A and DNMT3B polymorphisms associated with gastric cancer risk: A systematic review and meta-analysis. EBioMedicine. 2016;13:125-31.19.
Li H, Liu JW, Sun LP, Yuan Y. A meta-analysis of the association between DNMT1 polymorphisms and cancer risk. Biomed Res Int. 2017;2017:3971259.20.
Li XF, Shen M, Cai JW, Zeng YQ, Li M, Yang GL, et al. Association of interleukin-17 gene polymorphisms and Helicobacter pylori infection with gastric cancer susceptibility: a cumulative and comprehensive meta-analysis. Int J Clin Exp Med. 2015;8:17623-33.21.
Liang J, Xu YY, Zhang C, Xia QR. Association of XPG gene rs751402 polymorphism with gastric cancer risk: a meta-analysis in the Chinese population. Int J Biol Markers. 2018;3:174-9.22.
Lima-de-Faria A, Mitelman F, Blomberg J, Pfeifer-Ohlsson S. Telomeric location of retroviral oncogenes in humans. Hereditas. 1991;114:207-11.23.
Liu F, Li B, Wei Y, Chen X, Ma Y, Yan L, et al. P21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78,074 subjects. Mutagenesis. 2011;26:513-21.24.
Liu H, Wang S, Huang C. VEGFA +936C/T and ‑634G/C polymorphisms and gastric cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2011;12:1979-83.25.
Liu J, He C, Xu Q, Xing C, Yuan Y. NOD2 polymorphisms associated with cancer risk: a meta-analysis. PLoS One. 2014;9:e89340.26.
Liu X, Zhang X, Wang Z, Chang J, Wu Z, Zhang Z, et al. Genetic polymorphism of the phospholipase C epsilon 1 gene and risk of gastric cancer. Chin Med J (Engl). 2014;127:2511-7.27.
Lu R, Dou X, Gao X, Zhang J, Ni J, Guo L. A functional polymorphism of lymphotoxin-alpha (LTA) gene rs909253 is associated with gastric cancer risk in an Asian population. Cancer Epidemiol. 2012;36:e380-6.28.
Ma J, Wu D, Hu X, Li J, Cao M, Dong W. Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helico-bacter pylori related gastric cancer, peptic ulcer disease: A meta-analysis. PLoS One. 2017;12:e0176463.29.
Ma XP, Zhang T, Peng B, Yu L, Jiang de K. Association between microRNA poly-morphisms and cancer risk based on the findings of 66 case-control studies. PLoS One. 2013;8:e79584.30.
Ma Y, Wei X, Han G, Xue M, Li G, Li Y. Glutathione S-transferase P1 Ile105VAl polymorphism contributes to increased risk of gastric cancer in East Asians. Tumour Biol. 2013;34:1737-42.31.
Mo A, Zhao Y, Shi Y, Qian F, Hao Y, Chen J, et al. Association between polymorphisms of thymidylate synthase gene 5'- and 3'-UTR and gastric cancer risk: meta-analysis. Biosci Rep. 2016;36(6):e00429. 32.
Mocellin S, Verdi D, Pooley KA, Nitti D. Genetic variation and gastric cancer risk: a field synopsis and meta-analysis. Gut. 2015;64:1209-19.33.
Mouchiroud D, D'Onofrio G, Aissani B, Macaya G, Gautier C, Bernardi G. The distribution of genes in the human genome. Gene. 1991;100:181-7.34.
Musio A, Mariani T, Vezzoni P, Frattini A. Heterogeneous gene distribution reflects human genome complexity as detected at the cytogenetic level. Cytogenet Cell Genet. 2002;134:168-71.35.
Namazi A, Forat-Yazdi M, Jafari M, Farahnak S, Nasiri R, Foroughi E, et al. Association of interleukin-10 -1082 a/g (rs1800896) polymorphism with suscepti-bility to gastric cancer: meta-analysis of 6,101 cases and 8,557 controls. Arq Gastroenterol. 2018;55:33-40. 36.
Pabalan N, Jarjanazi H, Ozcelik H. Associations of the insertion/delet-ion polymorphism in the ACE gene and risk of gastric cancer: A meta-analysis. J Gastrointest Cancer. 2015;46:370-9.37.
Peng Q, Xu Y. Association between promoter polymorphisms of matrix meta-lloproteinase-1 and risk of gastric cancer. Onco Targets Ther. 2015;8:2519-26. 38.
Qi Q, Wang J, Huang B, Chen A, Li G, Li X, et al. Association of HOTAIR polymorphisms rs4759314 and rs920778 with cancer susceptibility on the basis of ethnicity and cancer type. Oncotarget. 2016;7:38775-84. 39.
Qin Z, Tang J, Li X, Yu Y, Zhang C, Han P, et al. Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis. Oncotarget. 2017;8:51766-78.40.
Rafiee L, Mohsenzadeh S, Saadat M. Nonrandom gene distribution on human chromosomes. EXCLI J. 2008;7:151-3.41.
Ribeiro RX, Nascimento CILL, Silva AMTC. Genotype association GSTM1 null and gastric cancer: evidence-based meta- analysis. Arq Gastroenterol. 2017;54:101-8.42.
Saadat M. Chromosomal distribution of schizophrenia susceptibility loci. J Mol Neurosci. 2013;51:401-2.43.
Saadat M. Distributions of susceptibility loci of Parkinson's disease and multiple sclerosis on human chromosomes. EXCLI J. 2014;13:724-7.44.
Saadat M. Distributions of susceptibility loci to late onset Alzheimer's disease on human chromosomes. EXCLI J. 2016;15:403-5. 45.
Saccone S, Caccio S, Kusuda J, Andreozzi L, Bernardi G. Identification of the gene richest bands in human chromosomes. Gene. 1996;174:85-94.46.
Saify K, Saadat M. Non-random distribution of breast cancer susceptibility loci on human chromosomes. Breast Cancer Res Treat. 2012;136:315-8.47.
Shen W, Hu P, Cao JQ, Liu XX, Shao JH. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies. J Int Med Res. 2014;42:1065-76.48.
Shi H, Shu H, Huang C, Gong J, Yang Y, Liu R, et al. Association of LEPR K109R polymorphisms with cancer risk: a systematic review and pooled analysis. J BUON. 2014;19:847-54.49.
Shi J, Li W, Ding X. Assessment of the association between ZBTB20 rs984150 polymorphism and gastric and esophageal cancer susceptibility: a meta-analysis. Int J Biol Markers. 2017;32:e96-e101.50.
Shi X, Jin H, Peng M, Li B, She M, Zhu T, et al. Association between NME1 polymorphisms and cancer sus-ceptibility: A meta-analysis based on 1644 cases and 2038 controls. Pathol Res Pract. 2018;214:467-74. 51.
Tai JJ, Hou CD, Wang-Wuu S, Wang CH, Leu SY, Wuu KD. A method for testing the non-randomness of chromosomal breakpoints. Cytogenet Cell Genet. 1993;63:147-50. 52.
Tian J, Pan F, Li J, Ma Y, Cen H, Pan HF, et al. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2012;13:945-51.53.
Wang H, Song K, Chen Z, Yu Y. Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations. PLoS One. 2013;8:e73126.54.
Wang HL, Zhou PY, Liu P, Zhang Y. ALDH2 and ADH1 genetic polymorphisms may contribute to the risk of gastric cancer: a meta-analysis. PLoS One. 2014;9:e88779.55.
Wang P, Wang J, Yu M, Li Z. Tumor necrosis factor-α T-857C (841799724) polymorphism and risk of cancers: A meta-analysis. Dis Markers. 2016;2016:4580323.56.
Wang Y, Chen Y, Jiang H, Tang W, Kang M, Liu T, et al. Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis. Int J Clin Exp Med. 2015;8:12661-73.57.
Wang Y, Jiang H, Liu T, Tang W, Ma Z. Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects. Int J Clin Exp Med. 2015;8:12448-62.58.
Wu SJ, Jiang SY, Wu J, Xiong GL. Association between EGF +61 A>G polymorphism and gastric cancer risk: A meta-analysis. J Huazhong Univ Sci Technol Med Sci. 2015;35:327-32.59.
Xie WQ, Wang XF. MiR-146a rs2910164 polymorphism increases the risk of digesti-ve system cancer: A meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41:93-102.60.
Xu GP, Zhao Q, Wang D, Xie WY, Zhang LJ, Zhou H, et al. The association between BRCA1 gene polymorphism and cancer risk: a meta-analysis. Oncotarget. 2018;9:8681-94.61.
Xu L, Zhou X, Xu L, Yin R. Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies. Tumour Biol. 2014;35:1661-9.62.
Xu Q, Liu JW, Yuan Y. Comprehensive assessment of the association between miRNA polymorphisms and gastric cancer risk. Mutat Res Rev Mutat Res. 2015;763:148-60.63.
Xu Y, He B, Li R, Pan Y, Gao T, Deng Q, et al. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies. PLoS One. 2014;9:e90090.64.
Yadav U, Kumar P, Rai V. NQO1 gene C609T polymorphism (dbSNP:rs1800566) and digestive tract cancer risk: A meta-analysis. Nutr Cancer. 2018;70:557-68.65.
Yan Q, Chen P, Lu A, Zhao P, Gu A. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis. PLoS One. 2013;8:e83710.66.
Yang TF, Guo L, Wang Q. Meta-analysis of associations between four polymorphisms in the matrix metallo-proteinases gene and gastric cancer risk. Asian Pac J Cancer Prev. 2014;15:1263-7.67.
Yang Y, Xiong Y, Li J, Wu C, Jiang J. Association of TIMP2-418G/C and TIMP2 -303G/A with gastric cancer: a meta-analysis. Onco Targets Ther. 2016;9:6801-8.68.
Ye Y, Yang C, Xu L, Fang D. MUC1 rs4072037 polymorphism is associated with decreased risk of gastric cancer: a meta-analysis. Int J Biol Markers. 2017;32:e284-e90.69.
Yu J, Deng Y, Chen JP. N-acetyl-transferase 2 status and gastric cancer risk: a meta-analysis. Tumour Biol. 2014;35:6861-5.70.
Zhang MX, Liu K, Wang FG, Wen XW, Song XL. Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies. Mol Clin Oncol. 2016;4:1031-8.71.
Zhang Q, Ma YY, Wang HJ, Shao CM, Zhang J, Ye ZY. Meta-analysis of the association between P53 codon 72 poly-morphisms and gastric cancer. J Surg Oncol. 2013;107:360-6.72.
Zhang Y, Liu C, Peng H, Zhang J, Feng Q. IL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis. PLoS One. 2012;7:e46017.73.
Zhang Y, Zeng X, Lu H, Ji H, Zhao E, Li Y. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis. Oncotarget. 2016;7:66109-18.74.
Zhang Y, Zeng X, Lu H, Li Y, Ji H. Association between interleukin 8 -251 A/T polymorphism and gastric cancer susceptibility: a meta-analysis based on 5286 cases and 8000 controls. Int J Clin Exp Med. 2015;8:22393-402.75.
Zhao DY, Cheng L, Yu J, Shen H. XRCC1 genetic polymorphism Arg339 Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision. Cancer Biomark. 2014;14:449-56.76.
Zhou Q, Wang C, Wang X, Wu X, Zhu Z, Liu B, et al. Association between TLR4 (+896A/G and +1196C/T) polymorphisms and gastric cancer risk: an updated meta-analysis. PLoS One. 2014;9:e109605.
Table 1: List of polymorphic loci associated with susceptibility to gastric cancer